However, in contrast to CTHRC1, FHL2 has been reported to positively regulate the expression of collagen types I and III in an FHL2-induced BLM-treated lung fibrosis model; this process tended to involve acceleration of lung inflammation rather than direct FHL2-induced fibrotic mechanisms [51–53]. This evidence concerns the gene FHL2 and pulmonary fibrosis.